• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

4'-Acetamidobiphenyl-3-carboxylic Acid (CAS No. 893737-71-8): An Overview of Its Structure, Synthesis, and Applications in Medicinal Chemistry

4'-Acetamidobiphenyl-3-carboxylic acid (CAS No. 893737-71-8) is a versatile organic compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural properties and potential therapeutic applications. This compound is characterized by its biphenyl core, which is substituted with an acetamido group at the 4' position and a carboxylic acid group at the 3 position. The combination of these functional groups imparts specific chemical and biological properties that make it a valuable candidate for various research and development activities.

The structure of 4'-acetamidobiphenyl-3-carboxylic acid is particularly noteworthy. The biphenyl moiety, consisting of two phenyl rings connected by a single bond, provides a rigid and planar framework that can interact with biological targets through π-π stacking and hydrophobic interactions. The acetamido group at the 4' position introduces hydrogen bonding capabilities, while the carboxylic acid group at the 3 position offers additional hydrogen bonding sites and can participate in salt formation, which is crucial for modulating the compound's solubility and bioavailability.

In terms of synthesis, 4'-acetamidobiphenyl-3-carboxylic acid can be prepared through several routes. One common method involves the coupling of 3-bromobenzoic acid with 4-acetaminophenylboronic acid using palladium-catalyzed cross-coupling reactions, such as the Suzuki-Miyaura coupling. This approach is widely used in organic synthesis due to its high efficiency and functional group tolerance. Another synthetic route involves the reaction of 4-acetamidophenylmagnesium bromide with 3-bromobenzoyl chloride, followed by hydrolysis to form the carboxylic acid. These synthetic methods have been optimized to achieve high yields and purity, making them suitable for large-scale production.

The biological activity of 4'-acetamidobiphenyl-3-carboxylic acid has been extensively studied in recent years. Research has shown that this compound exhibits potent anti-inflammatory properties, making it a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease (IBD). Studies have demonstrated that 4'-acetamidobiphenyl-3-carboxylic acid can inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, thereby reducing inflammation and tissue damage. Additionally, it has been found to possess antioxidant properties, which further contribute to its therapeutic potential.

Furthermore, 4'-acetamidobiphenyl-3-carboxylic acid has shown promise in the field of cancer research. Preclinical studies have indicated that this compound can induce apoptosis in cancer cells by modulating key signaling pathways involved in cell survival and proliferation. For instance, it has been reported to inhibit the activation of Akt and ERK1/2, which are crucial for cancer cell survival. These findings suggest that 4'-acetamidobiphenyl-3-carboxylic acid could be developed as a novel anticancer agent or used in combination with existing therapies to enhance treatment efficacy.

The pharmacokinetic properties of 4'-acetamidobiphenyl-3-carboxylic acid are also an important consideration for its potential therapeutic applications. Studies have shown that this compound exhibits good oral bioavailability and favorable pharmacokinetic profiles in animal models. Its low molecular weight and polar functional groups contribute to its good solubility and permeability across biological membranes. However, further optimization may be necessary to improve its metabolic stability and reduce potential side effects.

In conclusion, 4'-acetamidobiphenyl-3-carboxylic acid (CAS No. 893737-71-8) is a multifaceted compound with significant potential in medicinal chemistry. Its unique structural features, coupled with its anti-inflammatory and anticancer activities, make it an attractive candidate for further research and development. Ongoing studies are expected to uncover additional applications and optimize its therapeutic potential, paving the way for new treatments in various medical fields.

• 587-48-4(3-Acetamidobenzoic acid)
• 893737-78-5(3'-Acetamidobiphenyl-3-carboxylic acid)
• 855756-90-0(2'-Acetamidobiphenyl-3-carboxylic acid)
• 57742-39-9(Acedoben-d3)
• 331758-81-7(4-(3-Acetylaminophenyl)benzoic acid)
• 91950-09-3(3-acetamido-5-methylbenzoic acid)
• 6344-50-9(5-Acetylamino isophthalicacid)
• 15089-84-6(3-Amino-5-acetamidobenzoic Acid)
• 7743-39-7(3,5-bis(Acetylamino)benzoic Acid)
• 556-08-1(4-Acetamidobenzoic acid)